Get started
Author

Kavitha Rajsekar

Observed names: K. Rajsekar, Rajsekar Kavitha, Rajsekar, Kavitha
ORCID: 0000-0003-3042-8537
Observed ORCID: 0000-0003-3042-8537
OpenAlex ID: A5091908644
Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set
2022 · Gaurav Jyani, Atul Sharma, et al. · Value in Health · 131
Financial toxicity of cancer treatment in India: towards closing the cancer care gap
2023 · Shankar Prinja, Jyoti Dixit, et al. · Frontiers in Public Health · 96
Establishing reference costs for the health benefit packages under universal health coverage in India: cost of health services in India (CHSI) protocol
2020 · Shankar Prinja, Maninder Pal Singh, et al. · BMJ Open · 54
PDF
Health-related quality of life and its determinants among cancer patients: evidence from 12,148 patients of Indian database
2024 · Jyoti Dixit, Nidhi Gupta, et al. · Health and Quality of Life Outcomes · 45
PDF
Development of the Indian Reference Case for undertaking economic evaluation for health technology assessment
2023 · Deepshikha Sharma, Shankar Prinja, et al. · The Lancet Regional Health - Southeast Asia · 39
Translating Research to Policy: Setting Provider Payment Rates for Strategic Purchasing under India's National Publicly Financed Health Insurance Scheme
2021 · Shankar Prinja, Maninder Pal Singh, et al. · Applied Health Economics and Health Policy · 37
Cost-effectiveness of population-based screening for oral cancer in India: an economic modelling study
2023 · Pooja Dwivedi, Ayush Lohiya, et al. · The Lancet Regional Health - Southeast Asia · 36
Development of National Cancer Database for Cost and Quality of Life (CaDCQoL) in India: a protocol
2021 · Shankar Prinja, Jyoti Dixit, et al. · BMJ Open · 23
PDF
Impact of India's publicly financed health insurance scheme on public sector district hospitals: a health financing perspective
2022 · Shankar Prinja, Maninder Pal Singh, et al. · The Lancet Regional Health - Southeast Asia · 22
Polymorphic variants in DC-SIGN, DC-SIGNR and SDF-1 in high risk seronegative and HIV-1 patients in Northern Asian Indians
2008 · Omkar Chaudhary, Kavitha Rajsekar, et al. · Journal of Clinical Virology · 21
National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India
2021 · Shankar Prinja, Yashika Chugh, et al. · Applied Health Economics and Health Policy · 19
PDF
Adapting health technology assessment for drugs, medical devices, and health programs: Methodological considerations from the Indian experience
2021 · Shankar Prinja, Gaurav Jyani, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 19
Building Capacity for Evidence-Informed Priority Setting in the Indian Health System: An International Collaborative Experience
2020 · L.E. Downey, S. Dabak, et al. · Health Policy OPEN · 17
PDF
Cost of Surgical Care at Public Sector District Hospitals in India: Implications for Universal Health Coverage and Publicly Financed Health Insurance Schemes
2022 · Maninder Pal Singh, Shankar Prinja, et al. · PharmacoEconomics - Open · 13
PDF
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India
2022 · Yashika Chugh, Pankaj Bahuguna, et al. · Applied Health Economics and Health Policy · 12
PDF
Protocol for estimating the willingness-to-pay-based value for a quality-adjusted life year to aid health technology assessment in India: a cross-sectional study
2023 · Yashika Chugh, Gaurav Jyani, et al. · BMJ Open · 10
PDF
Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD): Toward improving the adherence of the patients with drug-sensitive tuberculosis in Nashik, Maharashtra
2022 · Somen Saha, Deepak Saxena, et al. · Frontiers in Public Health · 10
PDF
Application of Health Technology Assessment for Oncology Care in India: Implications for Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana
2021 · Nidhi Gupta, Gaurav Jyani, et al. · Indian Journal of Medical and Paediatric Oncology · 10
PDF
CHSI costing study–Challenges and solutions for cost data collection in private hospitals in India
2022 · Maninder Pal Singh, Riya Popli, et al. · PLoS ONE · 8
PDF
Economic evaluation of implementing a decentralised Hepatitis B virus diagnostic intervention under National Viral Hepatitis Control Programme in Tamil Nadu, South India
2020 · Malaisamy Muniyandi, Kirti Tyagi, et al. · Tropical Medicine & International Health · 8
Cost-effectiveness analysis of AI-assisted chest X-ray interpretation tools for TB screening: a rapid HTA
2025 · Devang Raval, Dhaval Parmar, et al. · Frontiers in Digital Health · 7
PDF
Estimating the Willingness-to-Pay per Quality-Adjusted Life-Year to Aid Health Technology Assessment in India
2025 · Yashika Chugh, Gaurav Jyani, et al. · Value in Health · 7
Significant reduction of seizure frequency in patients with drug-resistant epilepsy by vagus nerve stimulation: Systematic review and meta-analysis
2025 · Malaisamy Muniyandi, Karthick Chelvanayagam, et al. · Epilepsy Research · 5
Evaluating the cost-effectiveness of Cy-Tb for LTBI in India: a comprehensive economic modelling analysis
2024 · Malaisamy Muniyandi, Karikalan Nagarajan, et al. · International Health · 5
An economic evaluation of implementing a decentralized dengue screening intervention under the National Vector Borne Disease Control Programme in Tamil Nadu, South India
2021 · Malaisamy Muniyandi, Nagarajan Karikalan, et al. · International Health · 5
PDF
Works count: 47
Citation count: 686
H-index: 13
I10-index: 18
Year
Topic
Type